You are here

Article info

Article menu
Clinical/translational cancer immunotherapy
Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies

Authors

  • Martina Svenja Lutz CCU Translational Immunology, Department of Internal Medicine, UKT, Tubingen, GermanyCluster of Excellence iFIT (EXC 2180) Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tubingen, Germany PubMed articlesGoogle scholar articles
  • Boris Klimovich CCU Translational Immunology, Department of Internal Medicine, UKT, Tubingen, GermanyCluster of Excellence iFIT (EXC 2180) Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tubingen, Germany PubMed articlesGoogle scholar articles
  • Stefanie Maurer CCU Translational Immunology, Department of Internal Medicine, UKT, Tubingen, GermanyDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Jonas S Heitmann CCU Translational Immunology, Department of Internal Medicine, UKT, Tubingen, GermanyCluster of Excellence iFIT (EXC 2180) Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tubingen, Germany PubMed articlesGoogle scholar articles
  • Melanie Märklin CCU Translational Immunology, Department of Internal Medicine, UKT, Tubingen, GermanyCluster of Excellence iFIT (EXC 2180) Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tubingen, Germany PubMed articlesGoogle scholar articles
  • Latifa Zekri CCU Translational Immunology, Department of Internal Medicine, UKT, Tubingen, GermanyImmunology, University of Tübingen Interfaculty Institute of Cell Biology, Tubingen, Germany PubMed articlesGoogle scholar articles
  • Gundram Jung Cluster of Excellence iFIT (EXC 2180) Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tubingen, GermanyImmunology, University of Tübingen Interfaculty Institute of Cell Biology, Tubingen, Germany PubMed articlesGoogle scholar articles
  • Helmut R Salih CCU Translational Immunology, Department of Internal Medicine, UKT, Tubingen, GermanyCluster of Excellence iFIT (EXC 2180) Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tubingen, Germany PubMed articlesGoogle scholar articles
  • Clemens Hinterleitner Cluster of Excellence iFIT (EXC 2180) Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tubingen, GermanyDepartment of Medical Oncology and Pneumology (Internal Medicine VIII), UKT, Tubingen, Germany PubMed articlesGoogle scholar articles

Citation

Lutz MS, Klimovich B, Maurer S, et al
Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies
Journal for ImmunoTherapy of Cancer 2022;10:e003655. doi: 10.1136/jitc-2021-003655
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.